balance equationreview2024-03-30
Difference 2135000 exceeds tolerance 1642952.000. Presentation or filing-vintage differences need review.
Revenue
$670.48M
Fiscal year ended 2026-07-04Operating income
$79.98M
Fiscal year ended 2026-07-04Free cash flow
Unavailable
Fiscal year ended 2026-07-04Valuation, from the filing
| Public float | $349.70M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-28 |
|---|---|---|
| Float per share | $1.61 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 1.6× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 0.1× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 1.8× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-28, not today, and each multiple below it uses the figures for the fiscal year ending 2026-01-03 — the year that filing covered.
How this compares in its industry
Percentile among the Services-Home Health Care Services filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Long-term debt / equity | 6.62x | 100th | |
| Effective tax rate | -110.4% | 0th | |
| Gross margin | 33.3% | 100th | |
| Net margin | 9.2% | 80th | |
| Operating margin | 10.5% | 80th | |
| SBC / revenue | 1.0% | 75th | |
| Revenue YoY growth | 20.2% | 60th | |
| Current ratio | 1.32x | 50th |
Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $670.48M and net income of $40.29M for the fiscal year ended 2026-07-04. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Aveanna Healthcare Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Home Health Care Services.
Income
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $670.48M | $647.92M | $662.48M | $621.94M | $589.55M | $559.22M | $519.87M | $509.02M | $504.96M | $490.65M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $218.52M | $205.43M | $213.30M | $202.82M | $210.80M | $183.56M | $171.72M | $159.70M | $158.27M | $145.85M |
| Operating income | $79.98M | $69.33M | $71.04M | $53.58M | $80.03M | $51.80M | $45.77M | $34.02M | $37.13M | $22.87M |
| Net income | $40.29M | $41.65M | $178.75M | $14.06M | $27.02M | $5.19M | $29.18M | -$42.84M | $13.91M | -$11.17M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 224.86M | shares 222.10M | Unavailable | shares 222.23M | shares 210.44M | shares 206.24M | Unavailable | shares 193.36M | shares 196.87M | shares 192.24M |
| Pretax income | $56.47M | $44.98M | $39.24M | $13.42M | $44.14M | $10.15M | $26.94M | -$27.33M | $3.98M | $1.49M |
| Income tax expense | $16.18M | $3.32M | -$139.51M | -$647.00K | $17.11M | $4.96M | -$2.24M | $15.51M | -$9.93M | $12.66M |
| Diluted EPS | $0.18 | $0.19 | Unavailable | $0.06 | $0.13 | $0.03 | Unavailable | $-0.22 | $0.07 | $-0.06 |
| Selling, general & administrative | $97.08M | $95.79M | $97.64M | $95.40M | $90.07M | $91.39M | $88.74M | $88.18M | $87.97M | $87.91M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $97.20M | $189.27M | $193.26M | $145.87M | $100.74M | $71.49M | $84.29M | $78.46M | $47.66M | $42.61M |
| Total assets | $2.11B | $2.02B | $2.01B | $1.81B | $1.77B | $1.66B | $1.66B | $1.64B | $1.66B | $1.64B |
| Current assets | $478.09M | $575.30M | $560.23M | $502.60M | $449.92M | $407.62M | $392.67M | $381.37M | $364.00M | $336.04M |
| Total liabilities | $1.82B | $1.78B | $1.82B | $1.80B | $1.78B | $1.76B | $1.79B | $1.80B | $1.78B | $1.78B |
| Current liabilities | $411.32M | $390.43M | $424.46M | $409.69M | $414.23M | $388.31M | $402.17M | $406.04M | $389.15M | $381.93M |
| Total equity incl. NCI | $287.28M | $240.05M | $194.46M | $9.18M | -$11.99M | -$100.13M | -$123.55M | -$156.44M | -$118.97M | -$136.27M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $337.23M | $332.68M | $313.36M | $312.83M | $316.28M | $294.83M | $265.19M | $265.45M | $272.96M | $257.54M |
| Goodwill | $1.28B | $1.12B | $1.12B | $1.12B | $1.12B | $1.05B | $1.05B | $1.05B | $1.05B | $1.05B |
| Long-term debt | $1.28B | $1.28B | $1.29B | $1.29B | $1.27B | $1.27B | $1.27B | $1.28B | $1.27B | $1.28B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.93M | $4.35M | $49.72M | $33.20M | $51.57M | -$8.63M | $13.41M | $29.39M | $1.81M | -$11.97M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$175.37M | -$4.56M | -$1.95M | -$2.02M | -$15.98M | -$2.35M | -$1.53M | -$2.21M | -$1.27M | -$1.31M |
| Financing cash flow | $2.36M | -$3.78M | -$377.00K | $13.95M | -$6.34M | -$1.81M | -$6.05M | $3.62M | $4.51M | $11.94M |
| Net change in cash | -$92.08M | -$3.99M | $47.39M | $45.13M | $29.24M | -$12.79M | $5.83M | $30.80M | $5.05M | -$1.34M |
| Stock-based compensation | $4.14M | $4.15M | $3.95M | $4.96M | $5.16M | $11.00M | $4.98M | $4.90M | $3.50M | $4.08M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $2.85M | $3.04M | $2.73M | $2.60M | $2.62M | $2.59M | $2.45M | $2.59M | $2.83M | $2.91M |
Derived
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 32.6% | 31.7% | 32.2% | 32.6% | 35.8% | 32.8% | 33.0% | 31.4% | 31.3% | 29.7% |
| Operating margin | 11.9% | 10.7% | 10.7% | 8.6% | 13.6% | 9.3% | 8.8% | 6.7% | 7.4% | 4.7% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.6% | 0.6% | 0.6% | 0.8% | 0.9% | 2.0% | 1.0% | 1.0% | 0.7% | 0.8% |
| Current ratio | 1.16x | 1.47x | 1.32x | 1.23x | 1.09x | 1.05x | 0.98x | 0.94x | 0.94x | 0.88x |
| Revenue YoY growth | 13.7% | 15.9% | 27.4% | 22.2% | 16.8% | 14.0% | 8.6% | 6.5% | 7.0% | 5.2% |
| Net margin | 6.0% | 6.4% | 27.0% | 2.3% | 4.6% | 0.9% | 5.6% | -8.4% | 2.8% | -2.3% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 4.47x | Unavailable | 6.62x | 140.39x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 28.7% | 7.4% | -355.5% | -4.8% | 38.8% | 48.8% | -8.3% | Unavailable | -249.5% | 849.8% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AVAH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-19View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Reconciliation checks needing review
7 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2023-12-30
Difference 2135000 exceeds tolerance 1612985.000. Presentation or filing-vintage differences need review.
balance equationreview2023-09-30
Difference 2135000 exceeds tolerance 1654703.000. Presentation or filing-vintage differences need review.
balance equationreview2023-07-01
Difference 2135000 exceeds tolerance 1741402.000. Presentation or filing-vintage differences need review.
balance equationreview2023-04-01
Difference 2135000 exceeds tolerance 1730895.000. Presentation or filing-vintage differences need review.
balance equationreview2022-12-31
Difference 2135000 exceeds tolerance 1711760.000. Presentation or filing-vintage differences need review.
balance equationreview2022-10-01
Difference 2135000 exceeds tolerance 1973369.000. Presentation or filing-vintage differences need review.